𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phenotypical characterization of α-galactosidase A gene mutations identified in a large Fabry disease screening program in stroke in the young

✍ Scribed by De Brabander, Isabel; Yperzeele, Laetitia; Ceuterick-De Groote, Chantal; Brouns, Raf; Baker, Robert; Belachew, Shibeshih; Delbecq, Jean; De Keulenaer, Gilles; Dethy, Sophie; Eyskens, François; Fumal, Arnaud; Hemelsoet, Dimitri; Hughes, Derralynn; Jeangette, Sandrine; Nuytten, Dirk; Redondo, Patricia; Sadzot, Bernard; Sindic, Christian; Sheorajpanday, Rishi; Thijs, Vincent; Van Broeckhoven, Christine; De Deyn, Peter P.


Book ID
123184373
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
256 KB
Volume
115
Category
Article
ISSN
0303-8467

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


A sensitive mutation screening strategy
✍ Lianne C. Blanch; Cathy Meaney; C. Phillip Morris 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 660 KB

Fabry disease is an X-linked recessive lysosomal storage disorder caused by a deficiency of a-galactosidase A (a-gal; EC 3.2.1.22). In the past, it has been difficult to give an unequivocal diagnosis of carrier status in Fabry disease because of the overlap between normal and heterozygote enzyme lev

Molecular basis of fabry disease: Mutati
✍ Christine M. Eng; Robert J. Desnick 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 884 KB

Fabry disease, an X-linked inborn error of glycosphingolipid catabolism, results from mutations in the a-galactosidase A gene at Xq22.1. Studies of the mutations in unrelated Fabry families have identified a variety of lesions indicating the molecular genetic heterogeneity underlying the disease. Fo

A novel mutation (E358K) in the α-galact
✍ Dr. Takashi Miyazaki; Mitsuharu Kajita; Sachiko Ohmori; Naoki Mizutani; Toshimit 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB

The enzyme deficiency causes the intralysosomal accumulation of glycosphingolipids. The affected hemizygotes manifest acroparethesis, angiokeratoma, hypohidrosis, corneal opacities, and progressive vascular diseases of the kidney, heart, and brain. The human a-Gal A cDNA (Bishop et al., 1986) and ge